Hematologist
CION Cancer Clinics
When does adult ALL need a stem cell transplant? | CION Cancer Clinics
Most adults with ALL do not need a transplant. A donor stem cell transplant is usually advised when the leukaemia has a high chance of returning: MRD that stays detectable, high-risk genetic changes, a poor response to first treatment, or a relapse. This page explains how the decision is made, who a transplant may not suit, how donors are found, and what happens once it is advised. At CION Cancer Clinics, every leukaemia, MDS and MPN case is reviewed by our haematologist and discussed at a tumour board before a plan is agreed.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- When does an adult with ALL need a transplant?
- Which findings make a transplant more likely to be advised?
- How does a transplant compare with continuing treatment without one?
- Who might a transplant not suit?
- What happens between the advice and the transplant?
- What do families often believe about transplant in ALL?
- Common questions about transplant in adult ALL
The short answer
When does an adult with ALL need a transplant?
An adult with acute lymphoblastic leukaemia (ALL) is usually advised a donor stem cell transplant when the leukaemia has a high chance of coming back with chemotherapy alone. The main reasons are leukaemia still detectable on minimal residual disease (MRD) testing, high-risk genetic changes, a poor response to first treatment, or a relapse.
Most adults do not need one
Many adults complete treatment with chemotherapy, targeted tablets and antibody drugs, without a transplant. A transplant is a serious treatment with real risks. It is offered when the danger of the leukaemia returning is judged to be greater than the danger of the transplant itself.
What kind of transplant this means
In ALL, a transplant nearly always means an allogeneic transplant, using stem cells from a donor. Strong chemotherapy, sometimes with radiotherapy, clears the marrow. The donor's cells then build a new blood and immune system. Those new immune cells also attack any leukaemia left behind, which is a large part of why it works. A transplant using your own cells is rarely used in ALL.
The timing is part of the decision
A transplant usually works better when the leukaemia is in remission and MRD levels are as low as possible. That is why the question is often raised early, during consolidation, even if the transplant itself happens months later.
The reasons
Which findings make a transplant more likely to be advised?
No single finding decides it. Your haematologist weighs these together with your age, fitness and donor options.
MRD that does not clear
Leukaemia still detectable after induction and consolidation is one of the strongest reasons. An antibody drug may be used first to lower it.
High-risk genetics
Certain changes found at diagnosis carry a higher chance of relapse.
Examples on reports
- KMT2A (MLL) rearrangement
- Low hypodiploidy
- Complex chromosome changes
Slow or failed first response
If remission is not reached after induction, or is reached only after extra treatment, a transplant is usually recommended once remission is achieved.
Relapse
When ALL comes back, getting into a second remission and then proceeding to transplant is often the aim for fit adults.
CAR-T therapy is another option some people are referred for.Not sure whether this applies to you?
Ask an oncologistSide by side
How does a transplant compare with continuing treatment without one?
Donor transplant
Continuing without transplant
Stronger protection against relapse in high-risk ALL
Relies on chemotherapy, targeted drugs and maintenance
Higher short-term risk from infection and graft-versus-host disease
Lower short-term risk, but a higher chance of relapse if risk is high
Weeks in a specialised transplant unit, months of close follow-up
Mostly day-care visits and tablets at home
Needs a suitable donor and a qualified transplant centre
Can often continue closer to home
Being straight with you
Who might a transplant not suit?
A transplant is not the right step for everyone, even when the leukaemia is high risk. The strong treatment before it and the recovery after it place heavy demands on the body.
Health and fitness
Serious heart, lung, liver or kidney problems, poorly controlled diabetes, or an infection that has not settled can make the risks too high. Age matters less than overall fitness. Some older adults are offered a reduced-intensity transplant, which uses gentler treatment beforehand.
When the leukaemia is not controlled
A transplant given while leukaemia is active is far less likely to work. The team usually aims to reach remission first, sometimes with an antibody drug, before going ahead.
Practical realities
A transplant needs a caregiver who can stay close to the centre for several months, reliable transport and a plan for costs. These are fair things to discuss openly. They do not make you a bad family, and they can often be planned for.
Your own wishes count
Some people, after hearing the risks and benefits, choose not to have a transplant. That is a decision you are allowed to make. Ask the team what treatment would look like without one, so the choice is made with the full picture rather than in fear.
What this page cannot tell you
It cannot tell you whether you need a transplant or how it would go for you. Only your haematology team, with your results in front of them, can weigh that.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
If it is advised
What happens between the advice and the transplant?
-
Tumour board discussion
Your results are reviewed by the wider team. CION's haematology team presents the case and coordinates referral to qualified transplant centres. CION does not perform transplants itself.
-
Tissue typing of family members
Brothers and sisters give a blood or cheek swab sample for HLA typing, which checks how closely their tissue type matches yours.
-
Finding a donor
If no fully matched sibling is found, the centre may search donor registries or consider a half-matched family member, such as a parent or child.
-
Fitness tests
Heart, lung, kidney and dental checks, infection screening and an MRD test before admission.
-
Questions for the transplant centre
Ask how many adult ALL transplants they do, which donor type they recommend and why, how long the stay is likely to be, and who to call at night after discharge.
-
Admission and recovery
Conditioning treatment, the stem cell infusion, then a stay in the transplant unit until counts recover, followed by months of close follow-up.
Commonly believed
What do families often believe about transplant in ALL?
"A transplant is always the strongest choice, so we should insist on it."
For lower-risk leukaemia, the risks of transplant can outweigh the benefit. The right choice depends on your risk group, not on how intense the treatment sounds.
"Without a fully matched sibling, a transplant is not possible."
Unrelated registry donors and half-matched family donors are widely used now, including in India.
"Donating stem cells will harm my brother or sister."
Donors are carefully checked first. Most give cells from the blood through a machine, and their body replaces them. Donors can ask the centre about every step.
"Once a transplant is done, the leukaemia cannot return."
A transplant lowers the risk but does not remove it. Regular follow-up and MRD checks continue afterwards.
Did you know
Finding a donor can take time, so tissue typing of brothers and sisters is often started early, while treatment is still under way. Starting the search does not commit you to a transplant. It simply keeps the option open if the results point that way.
Questions we are asked
Common questions about transplant in adult ALL
Is a transplant needed for every adult with ALL?
No. Many adults complete treatment without one. A transplant is generally advised when MRD stays positive, the leukaemia has high-risk genetic changes, first treatment did not work well, or the leukaemia has relapsed. Your haematologist weighs these with your fitness and donor options.
Is Philadelphia-positive ALL always treated with a transplant?
Not any more. With targeted tablets and antibody drugs, some people with a deep MRD response may be treated without one. Others, especially if MRD remains detectable, are still advised a transplant. The decision is made case by case.
Who can be a donor?
A fully matched brother or sister is often the first choice. If none is available, a matched unrelated donor from a registry or a half-matched family member, such as a parent, child or sibling, may be used. The transplant centre decides which donor suits you.
Does CION do the transplant?
No. CION's haematology team evaluates the case, presents it at a tumour board, and coordinates referral and care with qualified transplant centres. Much of the treatment before a transplant, and some follow-up afterwards, can continue with the team you already know.
What is graft-versus-host disease?
It happens when the donor's immune cells attack the patient's healthy tissues, often the skin, gut or liver. It can be mild or serious, and it can appear early or months later. Medicines to calm the immune system are used to prevent and treat it. The transplant team will explain the signs to watch for.
Can an older parent have a transplant?
Sometimes. Overall fitness and organ health matter more than age alone. A reduced-intensity transplant, with gentler treatment beforehand, may be possible for some older adults. For others, continuing treatment without a transplant is the safer path. Ask the team to explain their reasoning either way.
How long will the family need to stay near the centre?
Usually several months in total, including the stay in the transplant unit and the early period of frequent visits afterwards. Families from outside Hyderabad often rent a place nearby. Ask the transplant centre for its exact follow-up schedule before you plan.
Is a transplant covered by Aarogyasri or insurance?
Aarogyasri, PM-JAY, CGHS, ECHS, EHS and cashless insurance may cover part of a transplant at empanelled centres, but packages, limits and eligibility change. Check your current cover with the scheme or insurer early, and ask the transplant centre's insurance desk for a written estimate.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Adult Acute Lymphoblastic Leukemia Treatment (PDQ), Patient Version
- Cancer Research UK — Acute lymphoblastic leukaemia (ALL)
- NHS — Stem cell and bone marrow transplants
- Leukemia & Lymphoma Society — Acute Lymphoblastic Leukemia (ALL)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Acute Lymphoblastic Leukaemia in AdultsThe overview of adult ALL, from diagnosis onwardsMRD-Guided Treatment in Adult ALLThe result that most often raises the transplant questionPhiladelphia-Positive ALL and TKI TreatmentHow targeted tablets have changed transplant decisionsRelapsed Adult ALL: CAR-T and Other OptionsOptions when leukaemia returns
Talk to us
Has a transplant been mentioned?
Tell us what has been found so far. CION's haematology team will go through the decision with you and coordinate with qualified transplant centres. One helpline serves every CION centre.